CoChat

A Trematode Parasite Derived Growth Factor Binds and Exerts Influences on Host Immune Functions via Host Cytokine Receptor Complexes

Open access

The DOI matches its Crossref record; 65 of the 65 references it cites were found in a registry or an index.

Abstract

The trematode Fasciola hepatica is responsible for chronic zoonotic infection globally. Despite causing a potent T-helper 2 response, it is believed that potent immunomodulation is responsible for rendering this host reactive non-protective host response thereby allowing the parasite to remain long-lived. We have previously identified a growth factor, FhTLM, belonging to the TGF superfamily can have developmental effects on the parasite. Herein we demonstrate that FhTLM can exert influence over host immune functions in a host receptor specific fashion. FhTLM can bind to receptor members of the Transforming Growth Factor (TGF) superfamily, with a greater affinity for TGF-β RII. Upon ligation FhTLM initiates the Smad2/3 pathway resulting in phenotypic changes in both fibroblasts and macrophages. The formation of fibroblast CFUs is reduced when cells are cultured with FhTLM, as a result of TGF-β RI kinase activity. In parallel the wound closure response of fibroblasts is also delayed in the presence of FhTLM. When stimulated with FhTLM blood monocyte derived macrophages adopt an alternative or regulatory phenotype. They express high levels interleukin (IL)-10 and arginase-1 while displaying low levels of IL-12 and nitric oxide. Moreover they also undergo significant upregulation of the inhibitory receptor PD-L1 and the mannose receptor. Use of RNAi demonstrates that this effect is dependent on TGF-β RII and mRNA knock-down leads to a loss of IL-10 and PD-L1. Finally, we demonstrate that FhTLM aids newly excysted juveniles (NEJs) in their evasion of antibody-dependent cell cytotoxicity (ADCC) by reducing the NO response of macrophages-again dependent on TGF-β RI kinase. FhTLM displays restricted expression to the F. hepatica gut resident NEJ stages. The altered fibroblast responses would suggest a role for dampened tissue repair responses in facilitating parasite migration. Furthermore, the adoption of a regulatory macrophage phenotype would allow for a reduced effector response targeting juvenile parasites which we demonstrate extends to an abrogation of the ADCC response. Thus suggesting that FhTLM is a stage specific evasion molecule that utilises host cytokine receptors. These findings are the first to clearly demonstrate the interaction of a helminth cytokine with a host receptor complex resulting in immune modifications that facilitate the non-protective chronic immune response which is characteristic of F. hepatica infection.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1371/journal.ppat.1005991

Cites

65 of 65 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig 1 FhTLM binds to and initiates mammalian host signalling pathways. (A) FhTLM was used to stimulate the TGF-β responsive cell line at the indicated doses. Relative light units (RLU) were converted to equivalent TGF-B concentration by comparison with a TGF-β standard curve. (B) This activity was inhibited by polyclonal serum raised against TGF-β. Plate-bound FhTLM was detected using the recombinant fusion proteins (C) bovine TGF-B R1-Fc and (D) bovine TGF-B RII-Fc. Results are reported as optical densities (OD) at 450nm. (E) Avidity of receptor-FhTLM interactions were measured using KSCN and presented as OD as a function of increasing KSCN molarity. (F) and (G) FhTLM and TGF-β, respectively, were used to coat ELISA plates (400ng/mL) overnight. Thereafter TGF-β1 and FhTLM were used in increasing concentrations shown to block the interaction of TGF-βRI-Fc or TGF-βRII-Fc. Data presented are means +/- SD of triplicates, experiments were repeated three times with similar results.
Fig 1 FhTLM binds to and initiates mammalian host signalling pathways. (A) FhTLM was used to stimulate the TGF-β responsive cell line at the indicated doses. Relative light units (RLU) were converted to equivalent TGF-B concentration by comparison with a TGF-β standard curve. (B) This activity was inhibited by polyclonal serum raised against TGF-β. Plate-bound FhTLM was detected using the recombinant fusion proteins (C) bovine TGF-B R1-Fc and (D) bovine TGF-B RII-Fc. Results are reported as optical densities (OD) at 450nm. (E) Avidity of receptor-FhTLM interactions were measured using KSCN and presented as OD as a function of increasing KSCN molarity. (F) and (G) FhTLM and TGF-β, respectively, were used to coat ELISA plates (400ng/mL) overnight. Thereafter TGF-β1 and FhTLM were used in increasing concentrations shown to block the interaction of TGF-βRI-Fc or TGF-βRII-Fc. Data presented are means +/- SD of triplicates, experiments were repeated three times with similar results.CC BY · PubMed Central
Fig 2 FhTLM can initiate transcription factor activation in primary host leukocytes. Naïve bovine PBMCs were incubated with FhTLM (200ng/mL) and subsequently prepared for immunoflouresence (A) to detect (B) Smad2/3 and (C) GATA1. (A) The upper row are cells stained with DAPI, middle row with anti-Smad2/3-FITC, and bottom row iIn both panels, the columns represent (from left to right) unstimulated PBMCs, TGF-β1 stimulated PBMCs, and FhTLM stimulated PBMCs. Following staining cytospins were examined at 40X magnification and the number of positive cells (i.e. FITC overlaid on DAPI) were calculated. This analysis was conducted over time for Smad2/3 (B) and at 3hrs for GATA1 (C). Data presented are means +/- SEM of triplicates, experiments were repeated three times with similar results. Results were analysed using a 1-way Anova and statistical significant differences are indicated on the graphs, *P<0.05 or **P<0.01.
Fig 2 FhTLM can initiate transcription factor activation in primary host leukocytes. Naïve bovine PBMCs were incubated with FhTLM (200ng/mL) and subsequently prepared for immunoflouresence (A) to detect (B) Smad2/3 and (C) GATA1. (A) The upper row are cells stained with DAPI, middle row with anti-Smad2/3-FITC, and bottom row iIn both panels, the columns represent (from left to right) unstimulated PBMCs, TGF-β1 stimulated PBMCs, and FhTLM stimulated PBMCs. Following staining cytospins were examined at 40X magnification and the number of positive cells (i.e. FITC overlaid on DAPI) were calculated. This analysis was conducted over time for Smad2/3 (B) and at 3hrs for GATA1 (C). Data presented are means +/- SEM of triplicates, experiments were repeated three times with similar results. Results were analysed using a 1-way Anova and statistical significant differences are indicated on the graphs, *P<0.05 or **P<0.01.CC BY · PubMed Central
Fig 3 FhTLM changes fibroblast responses. FhTLM was included as an additive in fibroblast CFU cultures (A) or in wound repair assays (C). (A) 3T3 fibroblasts were seeded at 6 cells/well in 6 well plates with the indicated additives. Cultures were incubated for 10 days, stained with crystal violet and CFUs were counted. (B) Cultures as above were established but with the addition of the specific TGF-β RI activin receptor-like kinase (ALK) inhibitor SB431542 (5μM). (C) 3T3 fibroblasts were seeded in 6 wells plates and grown to 80% confluence. Horizontal wounds were introduced and wells imaged at T0 and again at T24. TGF-β or FhTLM were included post-wounding at the indicated concentrations. Images were blinded and % wound closure was calculated as area of well visible at T24 relative to T0. (D) Cell lysates were collected from (C) and arginase levels were determined by enzyme assay and reported as mU/106 cells. For A, B and C data represents means +/- SEM of 4–6 measurements and experiments twice were repeated with similar results. Data in D represent combined data from (C) with N = 8–12 measurements +/- SEM per treatment. Results were analysed using a 1-way Anova and statistical significant differences are indicated on the graphs, P **P<0.01.
Fig 3 FhTLM changes fibroblast responses. FhTLM was included as an additive in fibroblast CFU cultures (A) or in wound repair assays (C). (A) 3T3 fibroblasts were seeded at 6 cells/well in 6 well plates with the indicated additives. Cultures were incubated for 10 days, stained with crystal violet and CFUs were counted. (B) Cultures as above were established but with the addition of the specific TGF-β RI activin receptor-like kinase (ALK) inhibitor SB431542 (5μM). (C) 3T3 fibroblasts were seeded in 6 wells plates and grown to 80% confluence. Horizontal wounds were introduced and wells imaged at T0 and again at T24. TGF-β or FhTLM were included post-wounding at the indicated concentrations. Images were blinded and % wound closure was calculated as area of well visible at T24 relative to T0. (D) Cell lysates were collected from (C) and arginase levels were determined by enzyme assay and reported as mU/106 cells. For A, B and C data represents means +/- SEM of 4–6 measurements and experiments twice were repeated with similar results. Data in D represent combined data from (C) with N = 8–12 measurements +/- SEM per treatment. Results were analysed using a 1-way Anova and statistical significant differences are indicated on the graphs, P **P<0.01.CC BY · PubMed Central
Fig 4 FhTLM induces a part alternative part regulatory macrophage phenotype. FhTLM (200ng/mL) was used to stimulate the bovine macrophages derived from blood monocytes. Thereafter levels of (A) nitric oxide (NO) levels, (B) arginase-1 levels, (C) IL-10, and (D) IL-12 in matched samples. Data in A-D is collected from the same experiment. In separate experiments using the same donors mannose receptor expression was also determined using immunofluorescence (E) and (F) increases in PD-L1 mRNA expression levels were quantified. Data represents means +/- SEM of triplicate measurments and experiments were repeated three times with similar results. Results were analysed using a 1-way Anova and statistical significant differences are indicated on the graphs; *P<0.05, **P<0.01.
Fig 4 FhTLM induces a part alternative part regulatory macrophage phenotype. FhTLM (200ng/mL) was used to stimulate the bovine macrophages derived from blood monocytes. Thereafter levels of (A) nitric oxide (NO) levels, (B) arginase-1 levels, (C) IL-10, and (D) IL-12 in matched samples. Data in A-D is collected from the same experiment. In separate experiments using the same donors mannose receptor expression was also determined using immunofluorescence (E) and (F) increases in PD-L1 mRNA expression levels were quantified. Data represents means +/- SEM of triplicate measurments and experiments were repeated three times with similar results. Results were analysed using a 1-way Anova and statistical significant differences are indicated on the graphs; *P<0.05, **P<0.01.CC BY · PubMed Central
Fig 5 FhTLM requires TGF-β RII to induce IL-10 and PD-L1. To access whether the effects of FhTLM on macrophages was specific to interactions with the host TGF-β receptor complex we employed siRNA to knock-down tgf-β RII expression. Primary macrophages were isolated and prior to stimulation were transfected with siRNA against tgf-β RII using Lipofectamine. (A) Expression of tgf-β RII mRNA were quantified by qPCR at the indicated timepoints post-transfection to monitor the effects of knock-down. At 12hrs post-transfection cells were treated with either FhTLM or TGF-β and TGF-β before IL-10 was measured 48hrs after stimulation (B) or PD-L1 was measured 6hrs after stimulation. All data is mean +/- SEM of triplicate measurements, (A) is data from one donor animal presentative of three individuals and data in (B) and (C) represent the means of 4 individual donor animals. Results in (B) and (C) were analysed using a 1-way Anova and statistical significant differences are indicated on the graphs; *P<0.05, **P<0.01, ***P<0.001.
Fig 5 FhTLM requires TGF-β RII to induce IL-10 and PD-L1. To access whether the effects of FhTLM on macrophages was specific to interactions with the host TGF-β receptor complex we employed siRNA to knock-down tgf-β RII expression. Primary macrophages were isolated and prior to stimulation were transfected with siRNA against tgf-β RII using Lipofectamine. (A) Expression of tgf-β RII mRNA were quantified by qPCR at the indicated timepoints post-transfection to monitor the effects of knock-down. At 12hrs post-transfection cells were treated with either FhTLM or TGF-β and TGF-β before IL-10 was measured 48hrs after stimulation (B) or PD-L1 was measured 6hrs after stimulation. All data is mean +/- SEM of triplicate measurements, (A) is data from one donor animal presentative of three individuals and data in (B) and (C) represent the means of 4 individual donor animals. Results in (B) and (C) were analysed using a 1-way Anova and statistical significant differences are indicated on the graphs; *P<0.05, **P<0.01, ***P<0.001.CC BY · PubMed Central
Fig 6 FhTLM reduces the capacity of macrophages to kill juvenile F. hepatica by ADCC. Macrophages were cultured from naïve donors as described in the presence of FhTLM or TGF-β for 24hrs. Following this macrophages were incubated with newly excysted juveniles (NEJs) in the presence of serum taken from naïve (non-immune) or experimentally infected, 13 weeks post-infection, animals (immune). After 6hr of incubation dead parasites were counted (A) and levels of NO in the supernatant determined (B). Experiments were repeated to test the effect of TGF-β RI ALK inhibitor, SB431542 (5μM),on macrophages before incubation with NEJs and serum and measurement of parasite killing (C) and NO levels (D). Data in (A) and (B) were tested for statistical significance using a 2-way anova to determine effect of non-immune vs immune sera and between PBS, FhTLM, and TGF-β macrophage treatment. Data in (C) and (D) were tested using 1-way Anova to determine the effect of inhibitor on TGF-β or FhTLM. **P<0.01 and ***P<0.001. Data displayed is mean +/- SEM and is representative of experiments conducted with 5 individual naïve macrophage donors, using 5 technical replicates per animal.
Fig 6 FhTLM reduces the capacity of macrophages to kill juvenile F. hepatica by ADCC. Macrophages were cultured from naïve donors as described in the presence of FhTLM or TGF-β for 24hrs. Following this macrophages were incubated with newly excysted juveniles (NEJs) in the presence of serum taken from naïve (non-immune) or experimentally infected, 13 weeks post-infection, animals (immune). After 6hr of incubation dead parasites were counted (A) and levels of NO in the supernatant determined (B). Experiments were repeated to test the effect of TGF-β RI ALK inhibitor, SB431542 (5μM),on macrophages before incubation with NEJs and serum and measurement of parasite killing (C) and NO levels (D). Data in (A) and (B) were tested for statistical significance using a 2-way anova to determine effect of non-immune vs immune sera and between PBS, FhTLM, and TGF-β macrophage treatment. Data in (C) and (D) were tested using 1-way Anova to determine the effect of inhibitor on TGF-β or FhTLM. **P<0.01 and ***P<0.001. Data displayed is mean +/- SEM and is representative of experiments conducted with 5 individual naïve macrophage donors, using 5 technical replicates per animal.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 1

  1. JM Zhang, 1997, Mitogenic and anti-proliferative signals for neural crest cells and the neurogenic action of TGF-beta1, Developmental dynamics: an official publication of the American Association of Anatomists, 208, 375, 10.1002/(SICI)1097-0177(199703)208:3<375::AID-AJA8>3.0.CO;2-F · DOI · Paper page

Cited by

See all 61

Metadata

Authors
Sulaiman, A. A., Zolnierczyk, K., Japa, O., Owen, J. P., Maddison, B. C., Emes, R. D., Hodgkinson, J. E., Gough, K. C., & Flynn, R. J.
Affiliations
  • University of Nottingham (GB)
  • University of Liverpool (GB)
Corresponding author
Flynn, Robin J.
Venue
PLOS Pathogens
Published
2016-11-02
Volume
12
Issue
11
Pages
e1005991
ISSN
  • 1553-7366 (ISSN-L)
  • 1553-7374
OpenAlex
W2548563955
Cited by
60
References
65
Citations by year
2026: 3 · 2025: 4 · 2024: 3 · 2023: 6 · 2022: 9 · 2021: 12 · 2020: 10 · 2019: 2 · 2018: 6 · 2017: 5
FWCI
4.47
Type
journal article
Language
en
Open access
Locations
  • PLoS Pathogens (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Repository@Nottingham (University of Nottingham) (publishedVersion, cc-by)
  • Repository@Nottingham (University of Nottingham) (submittedVersion, cc-by)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • Nottingham ePrints (University of Nottingham) (submittedVersion, cc-by)
  • Figshare (submittedVersion, cc-by)
  • Greater South Information System
Funders
Biotechnology and Biological Sciences Research Council (BB/L011530/1)
Topics
  • Life Sciences › Immunology and Microbiology › Parasitology › Parasites and Host Interactions
  • Life Sciences › Immunology and Microbiology › Parasitology › Helminth infection and control
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
Keywords
Fasciola hepatica, TGFBR2, Smad2/3 signaling, immunomodulation, regulatory macrophages, IL-10, PD-L1, CD206, alternative macrophage activation, antibody-dependent cellular cytotoxicity, tissue repair, parasite migration, newly excysted juveniles, host-parasite interactions, zoonotic trematode infection, wound closure
MeSH terms
Animals, Antibody-Dependent Cell Cytotoxicity, Disease Models, Animal, Enzyme-Linked Immunosorbent Assay, Fasciola hepatica, Fascioliasis, Fibroblasts, Fluorescent Antibody Technique, Host-Parasite Interactions, Macrophages, Transforming Growth Factors, Signal Transduction, Polymerase Chain Reaction, 3T3 Cells, Receptors, Cytokine, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.